« back

Target Ovarian Cancer: Translational Research Awards

  Friday, 28 May 2021 | Funding Deadline

Target Ovarian Cancer works to improve early diagnosis, fund life-saving research and provide much-needed support to everyone affected by ovarian cancer.

Translational Research Awards fund projects that will optimise and develop more effective and less toxic treatments for ovarian cancer, with a special focus on treatments that will improve overall survival. These awards aren't designed for basic or early discovery studies.

Some of the aims of the wards are:

• Identify new drug targets within subtypes of ovarian cancer and develop new targeted treatments
• Understand why tumours develop resistance to therapies, developing strategies to prevent and overcome resistance
• Develop new immunologic approaches to treating ovarian cancer
• Understand the effectiveness of existing drugs against different tumour subtypes
• Understand the effectiveness of specific drug combinations in subtypes
• Research to predict which patients will benefit from chemotherapy
• Develop appropriate treatments for older patients
• Identify prognostic markers that indicate response to treatment
• Develop robust surgical trials to validate new technologies and optimise treatments

 

Deadline for proposals: 28th May 2021

Find out more here